Why Do I Keep Getting Infections Down There?

Antibiotics kill surface bacteria but miss the deeper problem. Uropathogenic E. coli form intracellular bacterial communities inside bladder epithelial cells, creating reservoirs that antibiotics cannot reach. Gardnerella vaginalis builds biofilms on vaginal tissue that persist through antibiotic courses. When the surface infection clears, the reservoir waits. Stress, poor sleep, a hormonal dip, and the same organisms re-emerge from the same structures. Each antibiotic course selects for more resistant strains, a problem worsened by pandemic-era overprescription. The infections are not returning. They never fully left. I have talked to women who completed eight or nine courses of antibiotics in a single year. Each one a temporary reprieve. Each one breeding more resistance. The IDSA clinical practice guidelines now recommend against reflexive antibiotic prophylaxis precisely because resistance is outpacing drug development.

Let me explain the intracellular bacterial community mechanism because it changes how you think about recurrence. Dr. Scott Hultgren's lab at Washington University discovered that uropathogenic E. coli (UPEC) do not simply sit on the surface of bladder cells waiting to be washed away or killed by antibiotics. They invade the cells. Inside the epithelial cells, they form organised communities called intracellular bacterial communities (IBCs) that are protected from both the immune system and antibiotics. When the surface infection is cleared and the antibiotic course ends, these intracellular reservoirs reactivate, re-infect the bladder lumen, and the cycle begins again.

This is not a minor footnote in microbiology. It is the primary explanation for why antibiotics fail in recurrent UTIs. The drugs reach therapeutic concentrations in the urine and the bladder lumen but cannot penetrate the intracellular compartment where the bacteria are hiding. A woman who takes seven days of nitrofurantoin, clears her symptoms, and develops another infection three weeks later is not catching a new infection. She is experiencing reactivation of the same organisms from the same intracellular reservoirs.

The Gardnerella biofilm problem in recurrent BV follows a similar logic. Gardnerella species form structured biofilms on the vaginal epithelium that are 100 to 1,000 times more resistant to antibiotics than planktonic (free-floating) bacteria. A standard course of metronidazole kills the free-floating Gardnerella but leaves the biofilm intact. Within weeks, the biofilm repopulates the vaginal cavity, pH rises again, and the BV recurs. This is why recurrent infections in women cannot be solved by antibiotics alone. The reservoirs and biofilms persist beyond every course. The solution requires ecosystem restoration, not pathogen elimination.